Provided herein are compounds of the Formula (I): and pharmaceutically acceptable salts and compositions thereof, which are useful for treating a variety of conditions associated with histone deacetylases (HDAC).
-
Paragraph 00193
(2020/02/06)
NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
-
Page/Page column 51; 52
(2016/08/10)
QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
Provided herein are quinazoline compounds for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
-
Page/Page column 44
(2012/03/12)
More Articles about upstream products of 947533-45-1